Alere Inc (ALR.N)
18 Dec 2013
|Market Cap (Mil.):||$2,946.91|
|Shares Outstanding (Mil.):||81.88|
Aug 8 - The U.S. Food and Drug Administration approved health diagnostics and services company Alere Inc's test to treat two types of human immunodeficiency viruses (HIV) that cause the fatal infection, AIDS.
NEW YORK - An activist shareholder, which has been battling Alere Inc's management, said investors could more than double the value of their stock if they backed a plan for the health diagnostics and services provider to offload assets.
NEW YORK, July 8 - An activist shareholder, which has been battling Alere Inc's management, said investors could more than double the value of their stock if they backed a plan for the health diagnostics and services provider to offload assets.
|Tosoh Corporation (4042.T)||¥465||+2.00|
|Wal-Mart Stores, Inc. (WMT.N)||$77.43||+0.19|
|CVS Caremark Corporation (CVS.N)||$70.06||-0.08|
|McKesson Corporation (MCK.N)||$161.50||+0.91|
|Siemens AG (SIEGn.DE)||€98.01||+0.61|
|Walgreen Company (WAG.N)||$59.04||+2.10|
|Johnson & Johnson (JNJ.N)||$92.09||+0.11|
|Roche Holding Ltd. (ROG.VX)||CHF244.00||+2.20|
|Abbott Laboratories (ABT.N)||$37.84||-0.19|
|Becton, Dickinson and Co. (BDX.N)||$108.88||+0.86|
Earnings vs. Estimates
Analyst Research Reports
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ALERE INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.
Provider: Jefferson Research
Provider: ValuEngine, Inc.
Provider: Pechala's Reports